Charan Kaur Dardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charan Kaur Dardi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Aastha Pandey
Department of Community Medicine, MIMER Medical College, Talegaon Dabhade, Pune, India
1 shared publicationPandey Narayan
Department of Community Medicine, MIMER Medical College, Talegaon Dabhade, Pune, Maharashtra, India
1 shared publicationS. Maral Sanjivani
Symbiosis Institute of Health Sciences
1 shared publicationSadhana Sanjay Chate
Department of Microbiology, Maharashtra Institute of Medical Education and Research Medical College, Talegaon, Dabhade, Pune, Maharashtra, India
1 shared publication
Latest Publications
- Open Access
- 25 October 2017
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 4 (11) , 4174-4177
KAP study on bio-medical waste management among interns in a tertiary care hospital in Maharashtra
Background: Biomedical Waste Management is Hazardous and can lead to many infections and diseases. Interns are the future physicians of tomorrow and they should be conscious about safe disposal and segregation practices. So, the present study was undertaken to assess the knowledge and awareness about Biomedical waste management in Interns. The aims and objectives were to assess the knowledge and awareness about biomedical waste management in Interns. Methods: This cross sectional study was carried out in 51 interns. A pretested self-administered questionnaire on BMW management was given to the interns. Results: Out of 51 interns 26 were girls and 25 were boys. 63% knew correct definition of biomedical waste. 23.5% said that authorization is required by CPCB. 15% had undergone training but 60% were keen to attend training programme. 86% had correct knowledge about sources of generation of BMW and 94% had knowledge of Biohazard symbol. Only 68% had knowledge of segregation of waste but none had knowledge of correct colour coding. 88% answered that record maintenance was essential for biomedical waste management. 94% said that BMW is teamwork. Conclusions: There is a need for rigorous training programme for interns and monitoring is needed.
- 25 October 2017
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 4 (11) , 4174-4177
Open AccessKAP study on bio-medical waste management among interns in a tertiary care hospital in Maharashtra
Background: Biomedical Waste Management is Hazardous and can lead to many infections and diseases. Interns are the future physicians of tomorrow and they should be conscious about safe disposal and segregation practices. So, the present study was undertaken to assess the knowledge and awareness about Biomedical waste management in Interns. The aims and objectives were to assess the knowledge and awareness about biomedical waste management in Interns. Methods: This cross sectional study was carried out in 51 interns. A pretested self-administered questionnaire on BMW management was given to the interns. Results: Out of 51 interns 26 were girls and 25 were boys. 63% knew correct definition of biomedical waste. 23.5% said that authorization is required by CPCB. 15% had undergone training but 60% were keen to attend training programme. 86% had correct knowledge about sources of generation of BMW and 94% had knowledge of Biohazard symbol. Only 68% had knowledge of segregation of waste but none had knowledge of correct colour coding. 88% answered that record maintenance was essential for biomedical waste management. 94% said that BMW is teamwork. Conclusions: There is a need for rigorous training programme for interns and monitoring is needed.
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 7 (2) , 78-84
Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic
The worldwide epidemic of antibiotic resistance is in danger of ending the golden age of antibiotic therapy. Resistance impacts on all areas of medicine, and is making successful empirical therapy much more difficult to achieve. Staphylococcus aureus demonstrates a unique ability to quickly respond to each new antibiotic with the development of a resistance mechanism, starting with penicillin,until the most recent, linezolid and daptomycin. Methicillin resistant S. aureus (MRSA) has become endemic today in hospitals worldwide. Resistance to the newer antimicrobial-agents - linezolid, vancomycin, teicoplanin, and daptomycin are been reported and also the fear of pandrug-resistance. This study was carried out to know the antimicrobial resistant pattern of MRSA to newer antibiotic, to know any isolates are extensively-drug resistant (XDR)/pandrug resistant (PDR), inducible macrolide-lincosamide streptogramin B (iMLSB), and mupirocin resistance. Thirty-six MRSA isolates resistant to the routinely tested antibiotic were further tested for list of antibiotic by a group of international experts. Isolates were tested for iMLSB and mupirocin resistance by the disk diffusion method. Of 385 MRSA, 36 (9.35%) isolates of MRSA were resistant to the routinely tested antibiotic. Among these 36 MRSA isolates, none of our isolates were XDR/PDR or showed resistant to anti-MRSA cephalosporins (ceftaroline), phosphonic acids, glycopeptides, glycylcyclines, and fucidanes. Lower resistance was seen in oxazolidinones (2.78%), streptogramins (5.56%), lipopeptide (5.56%). Thirty-four (94.44%) isolates showed constitutive MLSB (cMLSB) resistance and two (5.56%) iMLSB phenotypes. High- and low-level mupirocin resistance were seen in 13 (36.11%) and six (16.67%), respectively. In our study, none of our isolates were XDR or PDR. No resistance was observed to ceftaroline, telavancin, teicoplanin, and vancomycin; but the presence of linezolid resistance (1, 2.28%) and daptomycin resistance (2, 5.56%) in our rural set-up is a cause of concern.
- 1 January 2015
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 7 (2) , 78-84
Open AccessStudy of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic
The worldwide epidemic of antibiotic resistance is in danger of ending the golden age of antibiotic therapy. Resistance impacts on all areas of medicine, and is making successful empirical therapy much more difficult to achieve. Staphylococcus aureus demonstrates a unique ability to quickly respond to each new antibiotic with the development of a resistance mechanism, starting with penicillin,until the most recent, linezolid and daptomycin. Methicillin resistant S. aureus (MRSA) has become endemic today in hospitals worldwide. Resistance to the newer antimicrobial-agents - linezolid, vancomycin, teicoplanin, and daptomycin are been reported and also the fear of pandrug-resistance. This study was carried out to know the antimicrobial resistant pattern of MRSA to newer antibiotic, to know any isolates are extensively-drug resistant (XDR)/pandrug resistant (PDR), inducible macrolide-lincosamide streptogramin B (iMLSB), and mupirocin resistance. Thirty-six MRSA isolates resistant to the routinely tested antibiotic were further tested for list of antibiotic by a group of international experts. Isolates were tested for iMLSB and mupirocin resistance by the disk diffusion method. Of 385 MRSA, 36 (9.35%) isolates of MRSA were resistant to the routinely tested antibiotic. Among these 36 MRSA isolates, none of our isolates were XDR/PDR or showed resistant to anti-MRSA cephalosporins (ceftaroline), phosphonic acids, glycopeptides, glycylcyclines, and fucidanes. Lower resistance was seen in oxazolidinones (2.78%), streptogramins (5.56%), lipopeptide (5.56%). Thirty-four (94.44%) isolates showed constitutive MLSB (cMLSB) resistance and two (5.56%) iMLSB phenotypes. High- and low-level mupirocin resistance were seen in 13 (36.11%) and six (16.67%), respectively. In our study, none of our isolates were XDR or PDR. No resistance was observed to ceftaroline, telavancin, teicoplanin, and vancomycin; but the presence of linezolid resistance (1, 2.28%) and daptomycin resistance (2, 5.56%) in our rural set-up is a cause of concern.
- Open Access
- 1 January 2015
- Published by Diva Enterprises Private Limited in International Journal of Medical Research & Health Sciences
- Vol. 4 (2) , 339-344
Biofilm formation and antimicrobial resistance pattern among uropathogens
Background Bacterial biofilms play an important role in urinary tract infections and is responsible for persistence infections and also the higher antimicrobial resistance is seen in biofilm forming uropathogen as compared to free floating bacteria. So the present study was undertaken with the aim to know the prevalence of biofilm formation and antimicrobial resistant pattern of biofilm producer and non-biofilm producing uropathogens. Materials & Methods A total of 146 Gram negative bacilli and 62 S. aureus isolated from patients suspected UTIs were tested for biofilm formation and antimicrobial susceptibility testing by Kirby-Bauer disc diffusion method on Mueller Hinton agar as per CLSI guidelines. Result Out of 208 isolates from urine, Biofilm formation was noted in 122(58.66%) and no biofilm formation in 86(41.35%). [Strong Biofilm formation in 76(36.54%) and weak biofilm formation in 46(22.12%). In our study, we noted biofilm and non-biofilm forming microorganism showed mark difference in antimicrobial resistance pattern. In Staphylococcus aureus striking difference was noted to ciprofloxacin (100% versus 33.33%) and azithromycin (96%versus 41.67%). Isolates showed no resistance to linezolid. Whereas isolates of Pseudomonas aeruginosa to netilin (100% versus 42.86%).And in other Gram negative bacilli difference was noted to gentamicin (87.93% versus 13.43%) and norfloxacin (84.48% versus 37.31%) Conclusion Biofilm forming isolates showed higher antimicrobial resistance as compared to non-biofilm producer. Thus, Uropathogen should be routinely screened for biofilm formation.
- 1 January 2015
- Published by Diva Enterprises Private Limited in International Journal of Medical Research & Health Sciences
- Vol. 4 (2) , 339-344
Open AccessBiofilm formation and antimicrobial resistance pattern among uropathogens
Background Bacterial biofilms play an important role in urinary tract infections and is responsible for persistence infections and also the higher antimicrobial resistance is seen in biofilm forming uropathogen as compared to free floating bacteria. So the present study was undertaken with the aim to know the prevalence of biofilm formation and antimicrobial resistant pattern of biofilm producer and non-biofilm producing uropathogens. Materials & Methods A total of 146 Gram negative bacilli and 62 S. aureus isolated from patients suspected UTIs were tested for biofilm formation and antimicrobial susceptibility testing by Kirby-Bauer disc diffusion method on Mueller Hinton agar as per CLSI guidelines. Result Out of 208 isolates from urine, Biofilm formation was noted in 122(58.66%) and no biofilm formation in 86(41.35%). [Strong Biofilm formation in 76(36.54%) and weak biofilm formation in 46(22.12%). In our study, we noted biofilm and non-biofilm forming microorganism showed mark difference in antimicrobial resistance pattern. In Staphylococcus aureus striking difference was noted to ciprofloxacin (100% versus 33.33%) and azithromycin (96%versus 41.67%). Isolates showed no resistance to linezolid. Whereas isolates of Pseudomonas aeruginosa to netilin (100% versus 42.86%).And in other Gram negative bacilli difference was noted to gentamicin (87.93% versus 13.43%) and norfloxacin (84.48% versus 37.31%) Conclusion Biofilm forming isolates showed higher antimicrobial resistance as compared to non-biofilm producer. Thus, Uropathogen should be routinely screened for biofilm formation.
- Open Access
- 1 November 2014
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 18 (11) , 716-721
Mupirocin resistance in nasal carriage ofStaphylococcus aureusamong healthcare workers of a tertiary care rural hospital
Mupirocin (pseudomonic acid A) is a topical antimicrobial agent with excellent antistaphylococcal and antistreptococcal activity. A nasal formulation is approved by the United States Food and Drug Administration for eradicating nasal carriage in adult patients as well as in health care personnel. Resistance to mupirocin has already been reported worldwide. The increasing prevalence of mupirocin resistance among Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) species could be an important threat to the future use of mupirocin against methicillin-resistant S. aureus (MRSA). Thus, this study was carried out to find the prevalence of mupirocin resistance in S. aureus and CoNS by disc diffusion and to determine the rates of high-level and low-level mupirocin resistance in S. aureus and CoNS by disc diffusion. A total of 140 healthcare workers (HCWs) (doctor, nursing staff, housekeeping staff) were randomly selected. S. aureus and CoNS isolates were tested for mupirocin resistance by the disk diffusion method using 5 μg and 200 μg mupirocin discs. MRSA isolates were tested for antibiotics by Kirby-Bauer disc-diffusion method as per Clinical and Laboratory Standards Institute guidelines. Out of 140 nasal swabs collected from HCWs, S. aureus was isolated in 38 (27.14%), and CoNS was isolated in 73 (52.14%). MRSA was isolated in 20 (14.28%) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) in 34 (24.29%. Methicillin-sensitive S. aureus (MSSA) and MSCoNS isolates were 100% sensitive to mupirocin, but two isolates from MRSA (1.43%) and five from MRCoNS (3.57%) were mupirocin resistant. The presence of mupirocin resistance in MRSA and MRCoNS is a cause for concern. It could be limited by regular surveillance and effective infection control initiatives so to inform health care facilities to guide therapeutic and prophylactic use of mupirocin.
- 1 November 2014
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 18 (11) , 716-721
Open AccessMupirocin resistance in nasal carriage ofStaphylococcus aureusamong healthcare workers of a tertiary care rural hospital
Mupirocin (pseudomonic acid A) is a topical antimicrobial agent with excellent antistaphylococcal and antistreptococcal activity. A nasal formulation is approved by the United States Food and Drug Administration for eradicating nasal carriage in adult patients as well as in health care personnel. Resistance to mupirocin has already been reported worldwide. The increasing prevalence of mupirocin resistance among Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) species could be an important threat to the future use of mupirocin against methicillin-resistant S. aureus (MRSA). Thus, this study was carried out to find the prevalence of mupirocin resistance in S. aureus and CoNS by disc diffusion and to determine the rates of high-level and low-level mupirocin resistance in S. aureus and CoNS by disc diffusion. A total of 140 healthcare workers (HCWs) (doctor, nursing staff, housekeeping staff) were randomly selected. S. aureus and CoNS isolates were tested for mupirocin resistance by the disk diffusion method using 5 μg and 200 μg mupirocin discs. MRSA isolates were tested for antibiotics by Kirby-Bauer disc-diffusion method as per Clinical and Laboratory Standards Institute guidelines. Out of 140 nasal swabs collected from HCWs, S. aureus was isolated in 38 (27.14%), and CoNS was isolated in 73 (52.14%). MRSA was isolated in 20 (14.28%) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) in 34 (24.29%. Methicillin-sensitive S. aureus (MSSA) and MSCoNS isolates were 100% sensitive to mupirocin, but two isolates from MRSA (1.43%) and five from MRCoNS (3.57%) were mupirocin resistant. The presence of mupirocin resistance in MRSA and MRCoNS is a cause for concern. It could be limited by regular surveillance and effective infection control initiatives so to inform health care facilities to guide therapeutic and prophylactic use of mupirocin.